Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x100px

Document › Details

Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg.

	Region	EU (European Union)
	Organisation	Pentixapharm Holding AG (FSE Prime Standard: PTP)
	Today	Pentixapharm (Group)
	Group	Pentixapharm (Group)
	Organisation 2	EMA (European Medicines Agency)
	Group	EU (govt)
	Product	PentixaFor (gallium-68-based companion diagnostic)
	Product 2	positron emission tomography (PET)
	Person	Riehle, Karolin (Eckert & Ziegler 202212 Investor Relations + PR)
	Person 2	Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma)

[Not for US, AU, CA, JP, ZA, et al.]

Record changed: 2024-09-29

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Pentixapharm (Group)

[1] |transkript [Kääb, Georg]. (9/24/24). "First German Life Sciences IPO since 2016 – Radiopharma Company Pentixapharm Lists at Frankfurt Stock Exchange. Interview by |transkript.de/Georg Kääb with Andreas Eckert"....
[2] Pentixapharm Holding AG. (9/23/24). "Press Release: Pentixapharm Holding AG Sets Price Range for Planned IPO [Not for US, AU, CA, JP, ZA, et al.]". Berlin & Würzburg....
[3] Pentixapharm Holding AG. (9/12/24). "Press Release: Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange [Not for US, AU, CA, JP, ZA, et al.]". Berlin & Würzburg....
[4] Pentixapharm AG. (7/3/24). "Press Release: Pentixapharm Acquires Target Discovery Business of Glycotope". Würzburg & Berlin....
[5] Eckert & Ziegler Strahlen- und Medizintechnik AG. (6/8/23). "Press Release: PentixaPharm Receives BfArM-Clearance for Its Therapeutic to Conduct a Clinical Trial in Lymphoma". Würzburg....
[6] PentixaPharm GmbH. (2/6/20). "Press Release: PentixaPharm Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics". Würzburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]